FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2617245268> ?p ?o ?g. }

• W2617245268 endingPage "e564" @default.
• W2617245268 startingPage "e564" @default.
• W2617245268 abstract "The aim of this cohort study was to compare a condensed schedule of consolidation therapy with high-dose cytarabine on days 1, 2 and 3 (HDAC-123) with the HDAC schedule given on days 1, 3 and 5 (HDAC-135) as well as to evaluate the prophylactic use of pegfilgrastim after chemotherapy in younger patients with acute myeloid leukemia in first complete remission. One hundred and seventy-six patients were treated with HDAC-135 and 392 patients with HDAC-123 with prophylactic pegfilgrastim at days 10 and 8, respectively, in the AMLSG 07-04 and the German AML Intergroup protocol. Time from start to chemotherapy until hematologic recovery with white blood cells >1.0 G/l and neutrophils >0.5 G/l was in median 4 days shorter in patients receiving HDAC-123 compared with HDAC-135 (P<0.0001, each), and further reduced by 2 days (P<0.0001) by pegfilgrastim. Rates of infections were reduced by HDAC-123 (P<0.0001) and pegfilgrastim (P=0.002). Days in hospital and platelet transfusions were significantly reduced by HDAC-123 compared with HDAC-135. Survival was neither affected by HDAC-123 versus HDAC-135 nor by pegfilgrastim. In conclusion, consolidation therapy with HDAC-123 leads to faster hematologic recovery and less infections, platelet transfusions as well as days in hospital without affecting survival." @default.
• W2617245268 created "2017-06-05" @default.
• W2617245268 creator A5003253888 @default.
• W2617245268 creator A5004269135 @default.
• W2617245268 creator A5009984400 @default.
• W2617245268 creator A5013231760 @default.
• W2617245268 creator A5014277422 @default.
• W2617245268 creator A5020375942 @default.
• W2617245268 creator A5022178280 @default.
• W2617245268 creator A5026255080 @default.
• W2617245268 creator A5026967725 @default.
• W2617245268 creator A5029448872 @default.
• W2617245268 creator A5029575769 @default.
• W2617245268 creator A5040272835 @default.
• W2617245268 creator A5046661856 @default.
• W2617245268 creator A5046761240 @default.
• W2617245268 creator A5047951694 @default.
• W2617245268 creator A5050224173 @default.
• W2617245268 creator A5052721036 @default.
• W2617245268 creator A5053168954 @default.
• W2617245268 creator A5053949970 @default.
• W2617245268 creator A5053983155 @default.
• W2617245268 creator A5055422099 @default.
• W2617245268 creator A5055477573 @default.
• W2617245268 creator A5058209680 @default.
• W2617245268 creator A5062688084 @default.
• W2617245268 creator A5064401286 @default.
• W2617245268 creator A5066615327 @default.
• W2617245268 creator A5067657650 @default.
• W2617245268 creator A5069866186 @default.
• W2617245268 creator A5070851905 @default.
• W2617245268 creator A5075459915 @default.
• W2617245268 creator A5084039929 @default.
• W2617245268 creator A5084493873 @default.
• W2617245268 creator A5089395073 @default.
• W2617245268 date "2017-05-26" @default.
• W2617245268 modified "2023-10-17" @default.
• W2617245268 title "Condensed versus standard schedule of high-dose cytarabine consolidation therapy with pegfilgrastim growth factor support in acute myeloid leukemia" @default.
• W2617245268 cites W1576941798 @default.
• W2617245268 cites W1608878503 @default.
• W2617245268 cites W1965035936 @default.
• W2617245268 cites W1985801522 @default.
• W2617245268 cites W1994978349 @default.
• W2617245268 cites W1997202142 @default.
• W2617245268 cites W2043216151 @default.
• W2617245268 cites W2044868127 @default.
• W2617245268 cites W2066915026 @default.
• W2617245268 cites W2073140442 @default.
• W2617245268 cites W2073866744 @default.
• W2617245268 cites W2116858301 @default.
• W2617245268 cites W2141034604 @default.
• W2617245268 cites W2142195688 @default.
• W2617245268 cites W2154327970 @default.
• W2617245268 cites W2237124828 @default.
• W2617245268 cites W2242685879 @default.
• W2617245268 cites W2318674152 @default.
• W2617245268 cites W2403586500 @default.
• W2617245268 cites W2526926662 @default.
• W2617245268 cites W2534021178 @default.
• W2617245268 cites W2559537906 @default.
• W2617245268 cites W2587631365 @default.
• W2617245268 cites W3175417087 @default.
• W2617245268 doi "https://doi.org/10.1038/bcj.2017.45" @default.
• W2617245268 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5518888" @default.
• W2617245268 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28548643" @default.
• W2617245268 hasPublicationYear "2017" @default.
• W2617245268 type Work @default.
• W2617245268 sameAs 2617245268 @default.
• W2617245268 citedByCount "41" @default.
• W2617245268 countsByYear W26172452682017 @default.
• W2617245268 countsByYear W26172452682018 @default.
• W2617245268 countsByYear W26172452682019 @default.
• W2617245268 countsByYear W26172452682020 @default.
• W2617245268 countsByYear W26172452682021 @default.
• W2617245268 countsByYear W26172452682022 @default.
• W2617245268 countsByYear W26172452682023 @default.
• W2617245268 crossrefType "journal-article" @default.
• W2617245268 hasAuthorship W2617245268A5003253888 @default.
• W2617245268 hasAuthorship W2617245268A5004269135 @default.
• W2617245268 hasAuthorship W2617245268A5009984400 @default.
• W2617245268 hasAuthorship W2617245268A5013231760 @default.
• W2617245268 hasAuthorship W2617245268A5014277422 @default.
• W2617245268 hasAuthorship W2617245268A5020375942 @default.
• W2617245268 hasAuthorship W2617245268A5022178280 @default.
• W2617245268 hasAuthorship W2617245268A5026255080 @default.
• W2617245268 hasAuthorship W2617245268A5026967725 @default.
• W2617245268 hasAuthorship W2617245268A5029448872 @default.
• W2617245268 hasAuthorship W2617245268A5029575769 @default.
• W2617245268 hasAuthorship W2617245268A5040272835 @default.
• W2617245268 hasAuthorship W2617245268A5046661856 @default.
• W2617245268 hasAuthorship W2617245268A5046761240 @default.
• W2617245268 hasAuthorship W2617245268A5047951694 @default.
• W2617245268 hasAuthorship W2617245268A5050224173 @default.
• W2617245268 hasAuthorship W2617245268A5052721036 @default.
• W2617245268 hasAuthorship W2617245268A5053168954 @default.
• W2617245268 hasAuthorship W2617245268A5053949970 @default.
• W2617245268 hasAuthorship W2617245268A5053983155 @default.
• W2617245268 hasAuthorship W2617245268A5055422099 @default.

• next